| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 156406-33-6 | [1R-[1alpha(Z),2beta(1E,3R*),3alpha]]-7-[3-Hydroxy-2-[3-Hydroxy-4-[3-(Trifluoromethyl)Phenoxy]-1-Butenyl]-5-Oxocyclopentyl]-5-Heptenoic Acid | C23H27F3O6 |
| 156408-67-2 | Zizyphoiside C | C49H78O18 |
| 156408-68-3 | Zizyphoiside D | C49H78O18 |
| 156409-45-9 | Gallinacin 2 | C205H322N60O48S6 |
| 156409-55-1 | Gallinacin 1alpha | C176H255N49O42S6 |
| 156413-21-7 | Methyl 7-Oxabicyclo[4.1.0]Hept-3-Ene-3-Carboxylate | C8H10O3 |
| 156413-61-5 | 7-O-(Triethylsilyl)-2’-O-tert-butyl(dimethyl)silyl Paclitaxel | C59H79NO14Si2 |
| 156413-67-1 | 2'-O-Methyl Paclitaxel | C48H53NO14 |
| 156418-97-2 | 5-(Allyloxy)-2-Pentanone | C8H14O2 |
| 156419-57-7 | 4-(Chloromethyl)-6,8-Dimethyl-2H-Chromen-2-One | C12H11ClO2 |
| 156419-94-2 | 5-Ethyl-2-Methoxy-Pyrimidine | C7H10N2O |
| 156420-69-8 | S-Allyl Butanethioate | C7H12OS |
| 156422-74-1 | Methyl 4-(Aminomethyl)-1H-Pyrrole-3-Carboxylate | C7H10N2O2 |
| 156422-77-4 | 3,5-Dihydropyrrolo[3,4-c]Pyrrol-1(2H)-One | C6H6N2O |
| 156423-97-1 | 2-Ethoxy-1,1,3,3-Tetramethylisoindoline | C14H21NO |
| 156428-81-8 | (4-Formyl-2-Methylphenyl)Boronic Acid | C8H9BO3 |
| 156429-14-0 | (1R,2S,3R,4S)-3-Acetyloxy-11-Diazonio-2,4,10-Trihydroxy-2-Methyl-9-Oxo-1-Propanoyloxy-3,4-Dihydro-1H-Benzo[b]Fluoren-5-Olate | C23H20N2O9 |
| 156431-08-2 | 5-Ethenyl-4-(2,3,4,9-Tetrahydro-1H-Pyrido[3,4-b]Indol-1-Ylmethyl)-6-[3,4,5-Trihydroxy-6-[[3,4,5-Trihydroxy-6-(Hydroxymethyl)Oxan-2-Yl]Oxymethyl]Oxan-2-Yl]Oxy-5,6-Dihydro-4H-Pyran-3-Carboxylic Acid | C32H42N2O14 |
| 156432-26-7 | Potassium 2,5-anhydro-4-deoxy-3-C-methyl-2-thiopent-4-enonate | C6H7KO3S |
| 156436-85-0 | Zizyphoiside E | C49H78O18 |
| 156436-90-7 | Motexafin Lutetium Hydrate | C52H72LuN5O14•xH2O |
| 156440-97-0 | Allyl 3-Oxo-1-Piperazinecarboxylate | C8H12N2O3 |
| 156451-08-0 | (S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3 | C13H12D3NO3 |
| 156453-50-8 | Dapoxetine Impurity 7 | C19H18O2 |
| 156453-51-9 | (alphaR)-N,N-Dimethyl-alpha-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine hydrochloride (1:1) | C21H23NO.HCl |
| 156453-53-1 | Dapoxetine Hydroxy Impurity | C19H18O2 |
| 156454-43-2 | 5-Bromo-7-methyl-1H-indazole | C8H7BrN2 |
| 156455-52-6 | 3-[(2R,3R)-3-Ethynyl-2-Oxiranyl]-1-Propanol | C7H10O2 |
| 156455-58-2 | 3-[(2R,3S)-3-Ethynyl-2-Oxiranyl]-1-Propanol | C7H10O2 |
| 156458-78-5 | 3,3'-(2,6-Pyridinediyldicarbonyl)bis-2-thiazolidinethione | C13H11N3O2S4 |
| 156458-89-8 | (5Z)-5,11-Dihydro-5-(3-hydroxypropylidene)-10H-dibenzo[a,d]cyclohepten-10-one | C18H16O2 |
| 156458-91-2 | (5Z)-5-(3-Bromopropylidene)-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-ol | C18H17BrO |
| 156458-92-3 | (5Z)-5-(3-Bromopropylidene)-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-one | C18H15BrO |
| 156459-82-4 | 2,2,2-Trifluoro-1-[4-(Hydroxymethyl)-1-Piperidinyl]Ethanone | C8H12F3NO2 |
| 156463-09-1 | (1R)-4-Azido-1-Carboxy-1-Butanaminium Chloride | C5H12ClN4O2 |
| 156463-85-3 | 4-Amino-1,2,5-Oxadiazole-3-Carbonitrile | C3H2N4O |
| 156465-30-4 | (2E)-N-Hydroxy-1-(3-Pyridinyl)-2-Propanimine | C8H10N2O |
| 156465-31-5 | (2E)-N-Hydroxy-1-(4-Pyridinyl)-2-Propanimine | C8H10N2O |
| 156465-32-6 | (1E)-N-Hydroxy-2-(4-Pyridinyl)Ethanimine | C7H8N2O |
| 156467-85-5 | alpha-Conotoxin Im-I | C52H78N20O15S4 |
| 156469-70-4 | Methyl 4-phenylpyrrolidine-3-carboxylate | C12H15NO2 |
| 156469-74-8 | cis-1-(Phenylmethyl)-3,4-pyrrolidinedicarboxylic acid diethyl ester | C17H23NO4 |
| 156472-94-5 | Ethyl 3-mercaptobutyrate | C6H12O2S |
| 156473-11-9 | 1-Methylbicyclo[2.2.1]Heptan-2-Amine | C8H15N |
| 156473-12-0 | 1-Methylbicyclo[2.2.1]Heptan-2-Amine | C8H15N |
| 156474-21-4 | (2R,3R)-3-[(t-Butoxycarbonyl)amino]-4-phenyl-1,2-epoxybutane | |
| 156474-22-5 | (2S,3R)-3-(tert-Butoxycarbonylamino)-1,2-epoxy-4-phenylbutane | C15H21NO3 |
| 156474-26-9 | 3-Thiomorpholinecarboxylic Acid 1-Oxide | C5H9NO3S |
| 156478-71-6 | 4-Boc-1-piperazineacetic acid | C11H20N2O4 |
| 156481-34-4 | Benzoyltaxol | C54H55NO15 |